Cancer Research includes companies working on scientific research aimed at understanding the causes, prevention, diagnosis, treatment, and potential cures for cancer. It includes many disciplines, from biology and genetics, to clinical trials and drug development, with the ultimate goal of improving cancer care and outcomes. Cancer research companies are developing life-saving treatments and diagnostics for a growing market in high demand. These companies constantly innovate, have a global reach, and form important strategic partnerships, which makes them appealing to investors looking for profits and supporting health progress.
Seems like PFE has hit the bottom at 24.81. Stock is staging a rebound.
Major Breakthrough: New Opdivo Treatment Regime Shows Promise for Early-Stage Lung Cancer Patients
Breakthrough: BMY's New Subcutaneous Cancer Drug Shows Superior Results Across Tumors
Added some shares at 24.93 to DCA.
The stock price has fallen outside the lower band. It should rebound back to lower band soon at 25.16. Waiting for hammer to appear.
Added some shares at 25.12 and 25.09 to DCA.
No comment yet